Moleculera Biosciences, Inc.
Moleculera Biosciences is a precision medicine company focused on identifying the root cause of chronic disorders driven by inflammation and immune dysfunction. They develop next-generation technologies for the identification, diagnosis, and treatment of patients with immune-mediated neuropsychiatric, cardiovascular, Long-COVID, and neuro-degenerative disorders. Their technology platform consists of three integrated components: precision medicine panels for autoantibody testing, a biobank and bioinformatics database to drive AI-developed algorithms, and a target identification program for companion diagnostics and therapeutics. Their signature product is the Autoimmune Brain Panel™, a patented 5-test blood test that helps clinicians identify autoimmune etiologies for neuropsychiatric symptoms, guiding treatment with anti-inflammatory or immune-modulatory agents. The company has multiple translational programs in development, including the Autoimmune Heart Panel™, Long-COVID Panel™, and Neuro-degenerative Disorder Panel™.
Moleculera Biosciences, Inc.
Moleculera Biosciences is a precision medicine company focused on identifying the root cause of chronic disorders driven by inflammation and immune dysfunction. They develop next-generation technologies for the identification, diagnosis, and treatment of patients with immune-mediated neuropsychiatric, cardiovascular, Long-COVID, and neuro-degenerative disorders. Their technology platform consists of three integrated components: precision medicine panels for autoantibody testing, a biobank and bioinformatics database to drive AI-developed algorithms, and a target identification program for companion diagnostics and therapeutics. Their signature product is the Autoimmune Brain Panel™, a patented 5-test blood test that helps clinicians identify autoimmune etiologies for neuropsychiatric symptoms, guiding treatment with anti-inflammatory or immune-modulatory agents. The company has multiple translational programs in development, including the Autoimmune Heart Panel™, Long-COVID Panel™, and Neuro-degenerative Disorder Panel™.